FDA NDC Directory · JSON-LD · Markdown

Leukine

NDC 71837-5843 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameSARGRAMOSTIM
Labeler / ManufacturerPartner Therapeutics, Inc.
Marketing categoryBiologic License Application · App BLA103362
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS SUBCUTANEOUS
Active ingredientsSARGRAMOSTIM (250 ug/mL)
Marketing started20230901
Package count1

External sources

Source: openFDA. Public-domain (CC0).